Pacific Biosciences Of California reported $-77523000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Accelerate Diagnostics AXDX:US -13249000 6.21M
Agilent A:US $ 360M 16M
Bruker BRKR:US $ 96.5M 28.9M
Danaher DHR:US $ 2172M 114M
Fluidigm FLDM:US -27503000 16.24M
General Electric GE:US $ -716M 3747M
Illumina ILMN:US $ 184M 143M
Myriad Genetics MYGN:US $ -25.6M 17.5M
Nanostring Technologies NSTG:US $ -37.47M 10.12M
Pacific Biosciences Of California PACB:US $ -77.52M 12.85M
Perkinelmer PKI:US $ 254.84M 55.3M
Quidel QDEL:US $ 620.66M 243.93M
Thermo Fisher Scientific TMO:US $ 2821M 1050M
Waters WAT:US $ 195.47M 66.73M